Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vitamin D and multiple sclerosis.
[Autonomic neuropathies].
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.
Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis.
Fatigue and sleep disturbance in multiple sclerosis.
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
Probabilistic Multiple Sclerosis Lesion Classification based on Modelling Regional Intensity Variability and Local Neighbourhood Information.
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident optic neuritis.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Therapy optimization: a new model for managing high-cost biologics.
B-cell targeted therapeutics in clinical development.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).
Incidence and distribution of extravascular compression of extracranial venous pathway in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.
NLRP3 Inflammasome and MS/EAE.
Inflammatory demyelinating diseases in children: an update.
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.

Pages